• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿8-羟基-2'-脱氧鸟苷作为心肌氧化应激标志物与活动性心脏结节病患者的室性心动过速相关。

Urinary 8-Hydroxy-2'-Deoxyguanosine as a Myocardial Oxidative Stress Marker Is Associated With Ventricular Tachycardia in Patients With Active Cardiac Sarcoidosis.

作者信息

Ishiguchi Hironori, Kobayashi Shigeki, Myoren Takeki, Kohno Michiaki, Nanno Takuma, Murakami Wakako, Oda Seiko, Oishi Keishi, Okuda Shinichi, Okada Munemasa, Suga Kazuyoshi, Yano Masafumi

机构信息

From the Division of Cardiology, Department of Medicine and Clinical Science (H.I., S.K., T.M., M.K., T.N., W.M., S. Oda, K.O., S. Okuda, M.Y.) and Department of Radiology (M.O.), Yamaguchi University Graduate School of Medicine, Ube, Japan; and Department of Radiology, St Hill Hospital, Ube, Japan (K.S.).

出版信息

Circ Cardiovasc Imaging. 2017 Dec;10(12). doi: 10.1161/CIRCIMAGING.117.006764.

DOI:10.1161/CIRCIMAGING.117.006764
PMID:29208596
Abstract

BACKGROUND

Recently, we reported that urinary 8-hydroxy-2'-deoxyguanosine (U-8-OHdG), an oxidative stress marker, reflected inflammatory activity in cardiac sarcoidosis (CS). Here, we investigated whether U-8-OHdG levels were associated with ventricular tachycardia (VT) in patients with CS.

METHODS AND RESULTS

This prospective cohort study enrolled 62 consecutive patients with CS, of whom 36 were diagnosed as having active CS based on abnormal F-flurodeoxyglucose accumulation in the heart on positron-emission tomography/computed tomography. The 36 patients with active CS were subdivided as having CS with sustained VT (CS-VT group; n=18) or CS without sustained VT (CS-nVT group; n=18). Twenty-seven patients diagnosed with idiopathic dilated cardiomyopathy served as heart failure controls. U-8-OHdG, brain natriuretic peptide, cardiac function indices, and immunohistological data from subendomyocardial biopsy samples were compared across groups. Immunohistochemical examination of ventricle biopsy samples revealed that the anti-8-OHdG antibody-positive area of cardiac tissue was significantly greater in CS-VT than in CS-nVT or dilated cardiomyopathy and significantly correlated with U-8-OHdG levels (n=58; =0.61; <0.00001), which were significantly higher in CS-VT than in CS-nVT (24.6±7.1 versus 15.2±3.8 ng/mg·Cr; <0.0001). Other baseline characteristics did not differ between the groups. Multivariate analysis indicated that U-8-OHdG was an independent determinant factor for VT. Receiver operating characteristic curve analysis to identify patients with VT resulted in a U-8-OHdG cutoff value of 17.5 ng/mg·Cr (sensitivity, 89%; specificity, 83%; area under the curve, 0.90).

CONCLUSIONS

U-8-OHdG levels are associated with VT in patients with active CS diagnosed by F-flurodeoxyglucose positron-emission tomography, providing additive and relevant information about the arrhythmia substrate.

摘要

背景

最近,我们报道了尿8-羟基-2'-脱氧鸟苷(U-8-OHdG)这一氧化应激标志物可反映心脏结节病(CS)中的炎症活动。在此,我们研究了CS患者中U-8-OHdG水平是否与室性心动过速(VT)相关。

方法与结果

这项前瞻性队列研究连续纳入了62例CS患者,其中36例基于正电子发射断层扫描/计算机断层扫描显示心脏中异常的氟脱氧葡萄糖积聚被诊断为活动性CS。36例活动性CS患者被进一步分为患有持续性VT的CS(CS-VT组;n = 18)或无持续性VT的CS(CS-nVT组;n = 18)。27例被诊断为特发性扩张型心肌病的患者作为心力衰竭对照。对各组的U-8-OHdG、脑钠肽、心功能指标以及心内膜下活检样本的免疫组织学数据进行了比较。心室活检样本的免疫组织化学检查显示,CS-VT组心脏组织的抗8-OHdG抗体阳性面积显著大于CS-nVT组或扩张型心肌病组,且与U-8-OHdG水平显著相关(n = 58;r = 0.61;P < 0.00001),CS-VT组的U-8-OHdG水平显著高于CS-nVT组(24.6±7.1对15.2±3.8 ng/mg·Cr;P < 0.0001)。其他基线特征在各组之间无差异。多因素分析表明,U-8-OHdG是VT的独立决定因素。用于识别VT患者的受试者工作特征曲线分析得出U-8-OHdG的截断值为17.5 ng/mg·Cr(敏感性为89%;特异性为83%;曲线下面积为0.90)。

结论

U-8-OHdG水平与通过氟脱氧葡萄糖正电子发射断层扫描诊断的活动性CS患者的VT相关,为心律失常基质提供了额外的相关信息。

相似文献

1
Urinary 8-Hydroxy-2'-Deoxyguanosine as a Myocardial Oxidative Stress Marker Is Associated With Ventricular Tachycardia in Patients With Active Cardiac Sarcoidosis.尿8-羟基-2'-脱氧鸟苷作为心肌氧化应激标志物与活动性心脏结节病患者的室性心动过速相关。
Circ Cardiovasc Imaging. 2017 Dec;10(12). doi: 10.1161/CIRCIMAGING.117.006764.
2
Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis.尿8-羟基-2'-脱氧鸟苷作为心脏结节病患者炎症活动的新型生物标志物。
Int J Cardiol. 2015;190:319-28. doi: 10.1016/j.ijcard.2015.04.144. Epub 2015 Apr 17.
3
An oxidative stress biomarker, urinary 8-hydroxy-2'-deoxyguanosine, predicts cardiovascular-related death after steroid therapy for patients with active cardiac sarcoidosis.一种氧化应激生物标志物——尿8-羟基-2'-脱氧鸟苷,可预测活动性心脏结节病患者接受类固醇治疗后的心血管相关死亡。
Int J Cardiol. 2016 Jun 1;212:206-13. doi: 10.1016/j.ijcard.2016.03.003. Epub 2016 Mar 17.
4
Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?¹⁸F-氟脱氧葡萄糖正电子发射断层扫描评估的心脏结节病的临床表现与心肌受累的部位和程度之间是否存在相关性?
Circ Cardiovasc Imaging. 2013 Sep;6(5):617-26. doi: 10.1161/CIRCIMAGING.112.000289. Epub 2013 Jul 24.
5
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.增强的氧化应激和心室动脉瘤的存在可预测心脏结节病的风险。
Heart. 2022 Mar;108(6):429-437. doi: 10.1136/heartjnl-2021-320244. Epub 2022 Jan 25.
6
Pleomorphism during Ventricular Tachycardia: A Distinguishing Feature between Cardiac Sarcoidosis and Idiopathic VT.室性心动过速期间的多形性:心脏结节病与特发性室性心动过速之间的一个鉴别特征。
Pacing Clin Electrophysiol. 2015 Jun;38(6):694-9. doi: 10.1111/pace.12626. Epub 2015 Apr 14.
7
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.心脏结节病患者心室内性心动过速导管消融的相关结局。
JAMA Cardiol. 2022 Feb 1;7(2):175-183. doi: 10.1001/jamacardio.2021.4738.
8
Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.室性心律失常患者中新诊断结节病的患病率:一项心脏磁共振成像和18F-FDG心肌PET研究
Int J Cardiovasc Imaging. 2021 Apr;37(4):1361-1369. doi: 10.1007/s10554-020-02090-2. Epub 2020 Nov 22.
9
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.心脏正电子发射断层扫描增强了疑似心脏结节病患者的预后评估。
J Am Coll Cardiol. 2014 Feb 4;63(4):329-36. doi: 10.1016/j.jacc.2013.09.022. Epub 2013 Oct 16.
10
Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia.镓-67闪烁扫描术在评估伴有室性心动过速的心脏结节病中的应用
Int J Cardiovasc Imaging. 2006 Jun-Aug;22(3-4):443-8. doi: 10.1007/s10554-005-9043-x. Epub 2006 Mar 14.

引用本文的文献

1
Emerging Biomarkers in Cardiac Sarcoidosis and Other Inflammatory Cardiomyopathies.心肌结节病和其他炎症性心肌病的新兴生物标志物。
Curr Heart Fail Rep. 2024 Dec;21(6):570-579. doi: 10.1007/s11897-024-00683-9. Epub 2024 Oct 4.
2
Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies.结节病的生物标志物和分子内型:组学和非组学研究的启示。
Front Immunol. 2024 Jan 4;14:1342429. doi: 10.3389/fimmu.2023.1342429. eCollection 2023.
3
Cardiac sarcoidosis: a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies.
心脏结节病:危险因素、发病机制、诊断、临床表现及治疗策略的全面综述
Front Cardiovasc Med. 2023 May 19;10:1156474. doi: 10.3389/fcvm.2023.1156474. eCollection 2023.
4
Antioxidants in Arrhythmia Treatment-Still a Controversy? A Review of Selected Clinical and Laboratory Research.抗氧化剂在心律失常治疗中——仍是一个争议话题?对部分临床和实验室研究的综述
Antioxidants (Basel). 2022 Jun 2;11(6):1109. doi: 10.3390/antiox11061109.
5
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.增强的氧化应激和心室动脉瘤的存在可预测心脏结节病的风险。
Heart. 2022 Mar;108(6):429-437. doi: 10.1136/heartjnl-2021-320244. Epub 2022 Jan 25.
6
Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy.外周血生物标志物在识别血清阳性且有发展为临床症状性克氏锥虫病心肌病风险个体中的预后性能。
Microbiol Spectr. 2021 Sep 3;9(1):e0036421. doi: 10.1128/Spectrum.00364-21. Epub 2021 Aug 25.
7
Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.心脏和肺部结节病的挑战:美国心脏病学会的最新综述
J Am Coll Cardiol. 2020 Oct 20;76(16):1878-1901. doi: 10.1016/j.jacc.2020.08.042.